当前位置:首页 > 专家介绍
黄钢 教授
学会任职: 主任委员
工作单位: 上海健康医学院
出诊信息: 点击查看
专业: 影像医学
亚专业: 核医学
专业主攻方向: 长期从事临床核医学研究和临床工作,善于在临床实践中积极开展新技术并应用于临床推广,一直位于多模态分子影像学技术发展的前沿。
主要学术成就、科技奖项、发明创造、著作、重要论文等

一、获奖: 1.2020年度华夏科技进步二等奖:肺癌代谢重编程机制与关键标志物研究及临床转化应用。(编号:2020LC0513P1)(第一完成人) 2.2014年度国家级教学成果二等奖:模拟医学平台结合示范病区,构建全面提升学生临床能力的新教学模式。(编号:20148550)(第一完成人) 3.2013年度国家科技进步二等奖:正电子发射断层扫描(PET)核医学装备系统的研制及产业化(编号:2013-J-235-2-03-R02) 4.2012年度“华夏医疗科技奖”一等奖:正电子发射断层显像技术的转化研究和国产化应用,证书编号:201201046P1101,(第一完成人) 二、专利20余项,其中代表性发明专利 1.一种自主式眼底摄影成像系统及方法,黄钢;孙九爱;何培忠;姚旭峰;刘红,ZL201710228148.4 2.血管内皮生长因子时间分辨荧光免疫分析方法及试剂盒,黄钢;盛世乐;韩源;张晨鹏,ZL200510111900.4 3.一种放射性氟标记Larotrectinib化合物及其制备方法,黄钢;李斌,ZL201811530573.X 三、著作:主编教材与专著30余部,近五年的代表性著作 1.黄钢等编著:核医学与分子影像。上海交通大学出版社, 2016 2.和水祥,黄钢主编:临床医学导论。人民卫生出版社, 2016 3.黄钢等主编:影像核医学与分子影像, 人民卫生出版社, 2016 4.王全师,黄钢主编:影像核医学与分子影像图谱。人民卫生出版社, 2017 5.黄钢,高再荣主编:核医学学习指导及习题集。人民卫生出版社, 2017 6.黄钢,陆秉杰主编:中国医学模拟教学管理规范。人民卫生出版社,2018。 7.李亚明,黄钢,李思进主编:核医学进展。北京 : 中华医学电子音像出版社, 2018 8.Tomio Inoue, David Yang, Gang Huang, Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation. Springer, 2017 9.黄钢主编:中国城市健康生活报告(2018)。社会科学文献出版社,2019 10.黄钢主编:上海市养老机构评价报告。社会科学文献出版社,2018。 11.Gang Huang, Nuclear Medicine in Oncology: Molecular Imaging and target Therapy. Springer, 2019 12.Hiroshi Toyama, Yaming Li, Jun Hatazawa, Gang Huang, Kazuo Kubota, PET/CT for Inflammatory Disease. Springer, 2020 四、论文,2021年度入选Elsevier中国高被引学者,近5年发表文章80余篇,其中代表性论文 1. Hua Q, Mi B, Xu F, et al.: Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1alpha axis. Theranostics 10: 4762-4778, 2020. IF:8.3 2. Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY and Cai W: ImmunoPET: Concept, Design, and Applications. Chem Rev 120: 3787-3851, 2020. IF:55 3. R Chen, Zhou X, Liu J, Huang G*. Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer[J]. Eur J Nucl Med Mol Imaging, 2019, 46(4): 848-854. 4. H Yang, Zhu R, Zhao X, Liu L, Zhou Z, Zhao L, Liang B, Ma W, Zhao J, Liu J, Huang G*. Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma[J]. Oncogene, 2019, 38(25): 4915-4931. 5. Q Hua, Jin M, Mi B, Xu F, Li T, Zhao L, Liu J, Huang G*. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis[J]. J Hematol Oncol, 2019, 12(1): 91. 6. L Wu, Tan J-L, Chen Z-Y, Huang G*. Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening[J]. Basic Res Cardiol, IF: 11, 2019, 114(5): 39. 7. L Shi, Yan H, An S, Shen M, Jia W, Zhang R, Zhao L, Huang G*, Liu J. SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer[J]. Mol Oncol, 2019, 13(2): 358-375. 8. P Li, Zhang A, Liu Y, Xu C, Tang L, Yuan H, Liu Q, Wang X, Feng D, Wang L, Huang G*, Song S. Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management[J]. Thyroid, 2019, 29(1): 93-100. 9. Shen M, Zhao X, Zhao L, Shi L, An S, Huang G*, Liu J.Met is involved in TIGAR-regulated metastasis of non-small-cell lung cancer. Mol Cancer. 2018,12;17(1):88. 10. W Jia, Zhao X, Zhao L, Yan H, Li J, Yang H, Huang G*, Liu J. Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4[J]. Oncogene, 2018, 37(13): 1685-1698. 11. Q Liu, Qian Y, Li P, Zhang S, Liu J, Sun X, Fulham M, Feng D, Huang G*, Lu W, Song S. (131)I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization[J]. Theranostics, , 2018, 8(3): 785-799. 12. Hua Q, Mi B, Huang G The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors.Crit Rev Oncol Hematol;126:112-120. 2018. 13. Chen, RH; Li, JJ; Zhou, X; Liu, JJ; Huang, G*; Fructose-1,6-Bisphosphatase 1 Reduces F-18 FDG Uptake in Hepatocellular Carcinoma.RADIOLOGY.284:844-853,2017. 14. Zhu, Z, Zhao, X, Zhao, L, Yang, H, Liu, L, Li, J, Wu, J, Yang, F, Huang, G*, Liu, J, p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A. ONCOGENE, 2016, 35(11):p.1399-1410. 15. Liu, L, Zhao, XP, Zhao, L, Li, JJ, Yang, H, Zhu, ZP, Liu, JJ, Huang, G*, Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth. CANCER RESEARCH, 2016, 76(5):1260-1272. 16. Chen, RH, Zhou, X, Liu, JJ, Huang, G*, Relationship Between F-18-FDG PET/CT Findings and HER2 Expression in Gastric Cancer. JOURNAL OF NUCLEAR MEDICINE,2016,57(7):1040-1044. 五、主持承担的代表性课题研究 1. 国家重大科研仪器研制项目(项目批准号:82127807;项目负责人):整环SPECT/能谱CT一体化分子影像仪的研发。(2021.11-2026.10) 2. 国家重点研发计划“合成生物学”重点专项《消化系统肿瘤高特异分子探针的创制与临床转化研究》(项目编号:2020YFA0909000)首席科学家,(2020.11-2025.10) 3. 国家自然基金重点项目(项目批准号:81830052;项目负责人):代谢影像组学智能预测肺癌靶向耐药的关键技术与应用(2019.1-2023.12) 4. 国家自然基金重点项目(项目批准号:81530053;项目负责人):高分辨分子成像在肿瘤代谢重编程机制及精准靶点定位的基础研究(2016-2020) 5. 国家自然基金项目(项目批准号:81471685;项目负责人):脂代谢显像与流量测定评价SREBP1对肺癌紫杉醇耐药的调节及其分子